Maximize cancer discoveries from challenging FFPE samples with OncoScan FFPE Express 2.0 Services
Developed in conjunction with leading cancer scientists, the second-generation OncoScan platform enables cancer researchers to obtain multiple cancer genome measurements from challenging FFPE samples with a single assay.
OncoScan FFPE Express 2.0 offers:
- High-resolution, cancer-relevant gene and whole-genome coverage
- High-quality data from 75 ng of input DNA
- Advanced data analysis
The new OncoScan 2.0 Array offers enhanced coverage of tumor suppressors and oncogenes, analysis of whole-genome copy number changes, copy-neutral loss of heterozygosity (LOH), and somatic mutation detection*.
*Effective probe conversion and signal intensity has been demonstrated for ~400 somatic mutations. Functional validation has been conducted in some cases. Affymetrix does not extend general performance claims or guarantees related to somatic mutation performance in specific cancer types.

